Holen Sie sich die Stockscreener-App
4.35
1.40%
0.06
Handel nachbörslich:
4.35
Schlusskurs vom Vortag:
$4.29
Offen:
$4.19
24-Stunden-Volumen:
246.04K
Relative Volume:
2.06
Marktkapitalisierung:
$245.91M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-98.43M
KGV:
-1.859
EPS:
-2.34
Netto-Cashflow:
$-119.33M
1W Leistung:
-1.58%
1M Leistung:
-16.18%
6M Leistung:
+21.17%
1J Leistung:
-41.45%
1-Tages-Spanne:
$4.12
$4.38
1-Wochen-Bereich:
$4.0207
$4.62
52-Wochen-Spanne:
$2.9448
$9.70
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
Firmenname
Foghorn Therapeutics Inc
Sektor
Branche
Telefon
617-586-3100
Adresse
500 TECHNOLOGY SQUARE, CAMBRIDGE
Vergleichen Sie FHTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
4.35 | 242.51M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Fortgesetzt | B. Riley Securities | Buy |
| 2025-04-23 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-01-30 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-03 | Eingeleitet | Jefferies | Buy |
| 2024-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2023-03-28 | Eingeleitet | BofA Securities | Buy |
| 2023-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-11-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-17 | Eingeleitet | Cowen | Outperform |
| 2020-11-17 | Eingeleitet | Goldman | Buy |
| 2020-11-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-17 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Foghorn Therapeutics Inc Aktie (FHTX) Neueste Nachrichten
Has Foghorn Therapeutics Inc. formed a bullish divergenceMarket Growth Report & Smart Allocation Stock Tips - newser.com
Using R and stats models for Foghorn Therapeutics Inc. forecasting2025 Key Lessons & Detailed Earnings Play Alerts - newser.com
Foghorn Therapeutics Inc. stock daily chart insightsJuly 2025 Volume & Growth Focused Stock Reports - newser.com
Using Python tools to backtest Foghorn Therapeutics Inc. strategies2025 Top Gainers & High Win Rate Trade Tips - newser.com
What does recent volatility data suggest for Foghorn Therapeutics Inc.July 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Can trapped investors hope for a rebound in Foghorn Therapeutics Inc.July 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Why Foghorn Therapeutics Inc. stock is rated strong buyTrade Volume Report & Weekly Return Optimization Alerts - newser.com
What institutional flow reveals about Foghorn Therapeutics Inc.Weekly Gains Report & Weekly Return Optimization Alerts - newser.com
Multi asset correlation models including Foghorn Therapeutics Inc.2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
Will Foghorn Therapeutics Inc. stock go up soonQuarterly Profit Review & Long-Term Capital Growth Strategies - newser.com
Published on: 2025-10-09 05:14:43 - newser.com
Foghorn Therapeutics (NASDAQ:FHTX) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Why Foghorn Therapeutics Inc. stock is seen as undervaluedEntry Point & Safe Entry Zone Tips - newser.com
Using Ichimoku Cloud for Foghorn Therapeutics Inc. technicalsBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Chart based exit strategy for Foghorn Therapeutics Inc.Market Risk Report & Verified Technical Trade Signals - newser.com
Detecting price anomalies in Foghorn Therapeutics Inc. with AIOil Prices & Free Technical Pattern Based Buy Signals - newser.com
How to monitor Foghorn Therapeutics Inc. with trend dashboardsMarket Performance Recap & Consistent Profit Alerts - newser.com
Finanzdaten der Foghorn Therapeutics Inc-Aktie (FHTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):